No Data
Iridex CEO Patrick Mercer Joins Board of Directors
Iridex Confirms That Local Coverage Determination L37531, Relating To Micro-Invasive Glaucoma Surgery Was Adopted As Scheduled And Wll Be Effective For Services Performed After Nov. 17
Express News | IRIDEX Corp: Encouraged That Transscleral Cyclophotocoagulation Remains Unaffected by Recent Glaucoma Lcd
Express News | IRIDEX Corp: IRIDEX's Cyclo G6 Product Family Is Unaffected by New Reimbursement Limitations
Express News | IRIDEX Comments on Changing Glaucoma Reimbursement Landscape
Iridex Comments on Changing Glaucoma Reimbursement Landscape
No Data
No Data